Nathalie Behar

Nathalie Behar

Auto-generated profile, based on publicly available information

Nathalie Behar

Service de Cardiologie, CHU de Rennes , Rennes

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Heart Rhythm
Verified
Journal Article
Closed access
MMMathilde Minier
Mathilde Minier
VPVincent Probst
Vincent Probst
PBPauline Berthome
Pauline Berthome
RTRomain Tixier
Romain Tixier
JBJean Briand
Jean Briand
JGJean-Baptiste Gourraud
Jean-Baptiste Gourraud

1 December 2018 in Computers in Biology and Medicine
Verified
Journal Article
Open access
MCMireia Calvo
Mireia Calvo
VLVirginie Lerolle
Virginie Lerolle
DRDaniel Romero
Daniel Romero
NBNathalie Béhar
Nathalie Béhar
Pedro GomisPedro Gomis
Pedro Gomis
AHAlfredo I. Hernández
Alfredo I. Hernández
The etiology of Brugada syndrome (BS) is complex and multifactorial, making risk stratification in this population a major challenge. Since changes in the autonomic modulation of these patients are commonly related to arrhythmic events, we analyze in this work whether the response to head-up tilt (HUT) testing on this population may provide useful, complementary information for risk stratification. In order to perform this analysis, a coupled physiological model integrating the cardiac electrical activity, the cardiovascular system and the baroreceptors reflex control of the autonomic function, in response to HUT is proposed. A sensitivity analysis was performed, based on a screening method, evidencing the influence of cardiovascular parameters on blood pressure and of baroreflex regulation on heart rate. The most sensitive parameters have been identified on a set of 20 subjects (8 controls and 12 BS patients), so as to assess subject-specific model parameters. According to the results, controls showed an increased sympathetic modulation after tilting, as well as a reduced left ventricular contractility was observed in symptomatic, with respect to asymptomatic BS patients. These results provide new insights regarding the autonomic mechanisms regulating the cardiovascular system in BS which might be used as a complementary source of information, along with classical electrophysiological parameters, for BS risk stratification.

1 December 2025 in EP Europace
Verified
Journal Article
Open access
HBHaran Burri
Haran Burri
CLChristophe Leclercq
Christophe Leclercq
NBNathalie Behar
Nathalie Behar
JDJean Claude Deharo
Jean Claude Deharo
MJMarek Jastrzebski
Marek Jastrzebski
JNJens Cosedis Nielsen
Jens Cosedis Nielsen
For patients with heart failure (HF) and bundle branch block, cardiac resynchronization therapy (CRT) by biventricular pacing (BiVP) has been found effective and has been widely used for around 20 years. The effects of BiVP are well documented in a row of large randomized controlled trials (RCTs) with long-term follow-up to include prolonged survival, less HF hospitalizations, and better quality of life for the patients. More recently, conduction system pacing (CSP) as His bundle pacing or left bundle branch area pacing has been introduced for CRT and shown to in best cases establish a normal or near-to-normal electrical activation of the left ventricular myocardium. Data from large RCTs documenting the beneficial effects of CSP are awaited. Currently, the question is to what extent the contemporary literature supports a transition from BiVP to CSP for CRT in patients with HF and bundle branch block. This Europace Controversy article presents opposing viewpoints on this topic. H.B., M.J., and J.J. argue in favour of CSP being superior to BiVP. Conversely, C.L., N.B., and J.C.D. advocate for BiVP still being the first choice for CRT. This Controversy aims to present data and their interpretation from different expert perspectives on an important topic in CRT for HF.

2 July 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
BMBaptiste Maille
Baptiste Maille
NBNathalie Behar
Nathalie Behar
PJPeggy Jacon
Peggy Jacon
JHJerome Hourdain
Jerome Hourdain
FFFrederic Franceschi
Frederic Franceschi
JDJean Claude Deharo
Jean Claude Deharo
In pacemaker-dependent (PMD) patients, treatment of device-related infection (DRI) leads to prolonged hospital stays1,2 and exposes patients to specific complications of temporary pacing, including lead dislodgement, cardiac tamponade, and reinfection of the temporary lead.3 Prolonged hospitalization also independently increases the risk of adverse events and morbidities.4,5 Therefore, strategies that can lead to simpler patient flow and shorter hospital stays are needed.6

25 August 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
MKMouna Ben Kilani
Mouna Ben Kilani
PJPeggy Jacon
Peggy Jacon
NBNicolas Badenco
Nicolas Badenco
CMChristelle Marquie
Christelle Marquie
POPierre Ollitrault
Pierre Ollitrault
PDPascal Defaye
Pascal Defaye
Despite recent improvements, inappropriate shocks emitted by implanted subcutaneous implantable cardioverter defibrillators (S-ICDs) remain a challenge in ‘real-life’ practice. We aimed to study the pre-implant factors associated with inappropriate shocks for the latest generation of S-ICDs. Three-hundred patients implanted with the third-generation S-ICD system for primary or secondary prevention between January 2017 and March 2020 were included in this multicentre retrospective observational study. A follow-up of at least 6 months and pre-implant screening procedure data were mandatory for inclusion. During a mean follow-up of 22.8 (±11.4) months, 37 patients (12.3%) received appropriate S-ICD shock therapy, whereas 26 patients (8.7%) experienced inappropriate shocks (incidence 4.9 per 100 patient years). The total number of inappropriate shock episodes was 48, with nine patients experiencing multiple episodes. The causes of inappropriate shocks included supraventricular arrhythmias (34.6%) and cardiac (30.7%) or extra-cardiac noise (38.4%) oversensing. Using multivariate analysis, we explored the independent factors associated with inappropriate shocks. These were the availability of less than three sensing vectors during pre-implant screening [hazard ratio (HR), 0.33; 95% confidence interval (CI), 0.11–0.93; P = 0.035], low QRS/T wave ratio in Lead I (for a threshold <3; HR, 4.79; 95% CI, 2.00–11.49; P < 0.001), history of supraventricular tachycardia (HR, 8.67; 95% CI, 2.80–26.7; P < 0.001), and being overweight (body mass index > 25; HR, 2.66; 95% CI, 1.10–6.45; P = 0.03). Automatic pre-implant screening data are a useful quantitative predictor of inappropriate shocks. Electrocardiogram features should be taken into consideration along with other clinical factors to identify patients at high risk of inappropriate shocks.

11 November 2025 in EP Europace
Verified
Journal Article
Open access
PJPeggy Jacon
Peggy Jacon
MBMouna Benkilani
Mouna Benkilani
Arnaud BissonArnaud Bisson
Arnaud Bisson
EMEloi Marijon
Eloi Marijon
ACAntoine Da Costa
Antoine Da Costa
PDPascal Defaye
Pascal Defaye
Aims: Leadless pacemakers (LLPs) offer a valuable option for selected patients requiring ventricular pacing. However, data on revision procedures—defined as any intervention on an implanted LLP to correct dysfunction or upgrade the system, with or without removal—remain scarce. This study aimed to evaluate the real-world incidence, characteristics, and outcomes of LLP revisions, with particular emphasis on the feasibility and safety of removal. Methods and results: This multicentre retrospective study involved 46 French centres performing LLP implantations between 2015 and 2023. Among 8994 Micra LLPs implanted, 100 revision procedures (1.1%) were performed in 100 patients, including 73 Micra VR and 27 Micra AV devices, at a median follow-up of 229 (68.5–629.8) days. Seventy revisions were managed without device removal, while 30 involved removal. Revision indications included device upgrade (55%), high pacing threshold (33%), battery depletion (3%), ventricular arrhythmias (3%), and miscellaneous causes (6%). No significant differences were observed in pacing indications, implantation characteristics, or initial device indication between the two groups. Revisions occurred significantly earlier in the removal group than in the group without removal [median 81.5 (8–211.5) days, vs. 334 (130.25–882.5) days, P < 0.001], with 80% occurring within 1 year. Device removal was successful in 97% of cases (one failure at 157 days of follow-up), with no major complications reported. Conclusion: LLP revisions are infrequent and predominantly managed without device removal. However, given the high procedural success rate and the low complication rate, device removal appears to be underutilized and should be considered more frequently on a case-by-case basis.